Two Sigma Investments
ALLR

Two Sigma Investments’s Allarity Therapeutics ALLR Stock Holding History

Two Sigma Investments’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30K Hold
27,492
– – ﹤0.01% 4497
2025
Q4 		$29.7K Buy
27,492
+13,582
+98% +$17.3K ﹤0.01% 3972
2025
Q3 		$22K Buy
+13,910
New +$17.5K ﹤0.01% 3595

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Two Sigma Investments's ALLR Position: Q1 2026 in Review

Two Sigma Investments held its Allarity Therapeutics (ALLR) position steady in Q1 2026 at 27,492 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #4497.

Two Sigma Investments first reported a position in ALLR in Q3 2025 and has held it in 3 quarters since. 14 funds tracked by Wall St. Rank hold ALLR as of Q1 2026.

  • Two Sigma Investments held 27,492 shares of Allarity Therapeutics worth $30K as of Q1 2026.
  • Two Sigma Investments left its Allarity Therapeutics share count unchanged in Q1 2026.
  • Allarity Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4497 holding.
  • Two Sigma Investments first reported a position in Allarity Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 14 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.